Class II · ModerateActive recall
Carbamazepine
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLot #: a) GS067429, GS068091, Exp 5/31/2028; b) GS067430, GS068090, Exp 5/31/2028
Where it was soldUSA Nationwide
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
CGMP deviations: tablets with black specks.
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
Made byTaro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA
| Brand name | CARBAMAZEPINE |
| Generic name | CARBAMAZEPINE |
| Active ingredient(s) | CARBAMAZEPINE |
| Distributed by / for | Golden State Medical Supply Inc. |
| NDC | 51407-215-10 |
Show the full FDA record
| Full product label | Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA |
| Recalling firm | Golden State Medical Supply Inc. |
| Distribution | USA Nationwide |
| Quantity | 1200 bottles |
| Recall initiated | 2026-08-07 |
| Report date | 2026-08-26 |
| Recall completed | — |
| Recall number | D-0771-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Camarillo CA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.